<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lu YJ</submitter><funding>Chang Gung Memorial Hospital</funding><pagination>1169</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10145679</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(4)</volume><pubmed_abstract>Thermosensitive cationic magnetic liposomes (TCMLs), prepared from dipalmitoylphosphatidylcholine (DPPC), cholesterol, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)]-2000, and didodecyldimethylammonium bromide (DDAB) were used in this study for the controlled release of drug/gene for cancer treatment. After co-entrapping citric-acid-coated magnetic nanoparticles (MNPs) and the chemotherapeutic drug irinotecan (CPT-11) in the core of TCML (TCML@CPT-11), SLP2 shRNA plasmids were complexed with DDAB in the lipid bilayer to prepare TCML@CPT-11/shRNA with a 135.6 ± 2.1 nm diameter. As DPPC has a melting temperature slightly above the physiological temperature, drug release from the liposomes can be triggered by an increase in solution temperature or by magneto-</pubmed_abstract><journal>Pharmaceutics</journal><pubmed_title>Thermosensitive Cationic Magnetic Liposomes for Thermoresponsive Delivery of CPT-11 and SLP2 shRNA in Glioblastoma Treatment.</pubmed_title><pmcid>PMC10145679</pmcid><funding_grant_id>CMRPD2L0102</funding_grant_id><pubmed_authors>Chen JP</pubmed_authors><pubmed_authors>Lu YJ</pubmed_authors><pubmed_authors>Hsu HL</pubmed_authors><pubmed_authors>Lan YH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Thermosensitive Cationic Magnetic Liposomes for Thermoresponsive Delivery of CPT-11 and SLP2 shRNA in Glioblastoma Treatment.</name><description>Thermosensitive cationic magnetic liposomes (TCMLs), prepared from dipalmitoylphosphatidylcholine (DPPC), cholesterol, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)]-2000, and didodecyldimethylammonium bromide (DDAB) were used in this study for the controlled release of drug/gene for cancer treatment. After co-entrapping citric-acid-coated magnetic nanoparticles (MNPs) and the chemotherapeutic drug irinotecan (CPT-11) in the core of TCML (TCML@CPT-11), SLP2 shRNA plasmids were complexed with DDAB in the lipid bilayer to prepare TCML@CPT-11/shRNA with a 135.6 ± 2.1 nm diameter. As DPPC has a melting temperature slightly above the physiological temperature, drug release from the liposomes can be triggered by an increase in solution temperature or by magneto-</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-04T19:18:08.116Z</modification><creation>2025-04-04T19:18:08.116Z</creation></dates><accession>S-EPMC10145679</accession><cross_references><pubmed>37111654</pubmed><doi>10.3390/pharmaceutics15041169</doi></cross_references></HashMap>